Check Availability
Price :
-
MRP ₹ 4499/- -
Offer Price ₹ 3999/-
Description
This panel includes next higher level of tumour markers in a female. This panel is used by physicians for prognosis, determine the stage of cancer, detect cancer that remains after treatment, assess how well a treatment is working or wether the treatment has stopped working. Parameters in this panel screens for gestational trophoblastic disease [GTD], Germ cell tumours, liver, breast , lung, skin and stomach cancers, hormone related cancers , thyroid cancers ,Tumour markers with CBC gives an in-depth view of the blood picture.
Special preparation
No
Fasting required
No
Sample type
Blood
- CA 125
- CA 15.3
- CA 19.9
- AFP
- CEA
- HCG
- Calcitonin
- Thyroglobulin
- White blood cell count
- Red blood cell count
- Haemoglobin
- PCV
- MCV
- MCH
- MCHC
- RDW (CV)
- Platelet count
- Neutrophils
- Lymphocyte
- Monocyte
- Eosinophil
- Basophil
- Absolute Neutrophil Count
- Absolute Lymphocyte Count
- Absolute Monocyte Count
- Absolute Eosinophil Count
- MPV
- PDW
Categories:
Cancer, Chronic Diseases, Test Menu
- CA 125
- CA 15.3
- CA 19.9
- AFP
- CEA
- HCG
- Calcitonin
- Thyroglobulin
- White blood cell count
- Red blood cell count
- Haemoglobin
- PCV
- MCV
- MCH
- MCHC
- RDW (CV)
- Platelet count
- Neutrophils
- Lymphocyte
- Monocyte
- Eosinophil
- Basophil
- Absolute Neutrophil Count
- Absolute Lymphocyte Count
- Absolute Monocyte Count
- Absolute Eosinophil Count
- MPV
- PDW
Why Bio5?
Bio5 has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more. We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.